Atlas Trials

Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)

Clinical trial NCT02360956 · UNKNOWN

Trial details

NCT number
NCT02360956
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Atherosclerosis
Start date
2014-12-01
Primary completion
2016-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.